Medifast Inc
MED· NYSE
MEDMedifast Inc
Filed Feb 20, 2024 · 10-K · 51 days after period end · 0001628280-24-005620
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 |
|---|---|---|---|---|
| Revenue | $191.01M | $337.25M | $377.83M | $264.91M |
| Net Income | $6.04M | $26.52M | $34.02M | $27.99M |
| EPS Diluted | — | — |
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
| — |
| $2.36 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2023 · filed Feb 20, 2024 · 51 d after period end
